Lee Moon-Soo, Yang Jae-Won, Ko Young-Hoon, Han Changsu, Kim Seung-Hyun, Lee Min-Soo, Joe Sook-Haeng, Jung In-Kwa
Korea University Medical Center, Seoul, Korea.
Child Psychiatry Hum Dev. 2008 Jun;39(2):201-9. doi: 10.1007/s10578-007-0081-6. Epub 2007 Aug 31.
We evaluated plasma levels of DHEA-S and cortisol before and after treating ADHD patients with one of two medications: methylphenidate (n = 12) or bupropion (n = 10). Boys with ADHD (combined type) were evaluated with the Korean ADHD rating scale (K-ARS) and the computerized ADHD diagnostic system (ADS). All assessments were measured at baseline and repeated after 12 weeks. There were significant clinical improvements in both treatment groups as measured by K-ARS and ADS. DHEA-S levels increased from baseline to endpoint, but cortisol levels did not change significantly. This study suggests that both methylphenidate and bupropion increase plasma levels of DHEA-S in boys with ADHD.
我们评估了12名服用哌甲酯(n = 12)或安非他酮(n = 10)这两种药物之一治疗的多动症患者治疗前后的脱氢表雄酮硫酸酯(DHEA-S)和皮质醇的血浆水平。患有多动症(混合型)的男孩使用韩国多动症评定量表(K-ARS)和计算机化多动症诊断系统(ADS)进行评估。所有评估均在基线时进行,并在12周后重复进行。通过K-ARS和ADS测量,两个治疗组均有显著的临床改善。DHEA-S水平从基线升高至终点,但皮质醇水平无显著变化。本研究表明,哌甲酯和安非他酮均可提高多动症男孩血浆中DHEA-S的水平。